SYSTEMIC LUPUS ERTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lupus drug trial hopes to tame the immune system
Disease control Recruiting nowThis early-stage trial tests a new drug called GR1803 in 44 people with systemic lupus erythematosus (SLE), an autoimmune disease. The goal is to see if the drug is safe and can help control lupus symptoms. Participants must have moderate to severe disease and be on standard trea…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment using specially engineered immune cells (CAR-NK cells) in 36 children with B-cell-related autoimmune diseases like lupus and IgA nephropathy. The goal is to see if these cells can safely control the disease by targeting and calming the…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Cord blood cells could tame lupus – first human trial begins
Disease control Recruiting nowThis early-stage study tests a single injection of cells from donated umbilical cords in 10 adults with active lupus. The goal is to see if the treatment is safe and can improve kidney function and reduce disease activity when added to standard care. Participants will have regula…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1 • Sponsor: LiveKidney.Bio • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
What really causes fatigue? new study aims to find out
Knowledge-focused Recruiting nowThis study aims to understand the different types of fatigue people experience, whether from cancer, lupus, ME/CFS, or other conditions. Researchers will compare fatigued and non-fatigued adults using interviews, questionnaires, physical tests, and optional brain scans. The goal …
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated May 26, 2026 03:32 UTC
-
Can vaccine timing boost protection for the immunocompromised?
Knowledge-focused Recruiting nowThis study looks at the best way to give COVID-19 booster and flu vaccines to people with weakened immune systems, such as those with rheumatoid arthritis, HIV, or organ transplants. Researchers will compare giving both vaccines at the same time versus one month apart, and also t…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC